Biosite Acquired By Beckman Coulter

San Diego-based Biosite, a biomedical company commercialization products in the area of proteomics, has been acquired by Fullerton-based Beckman Coulter, in a deal worth $1.55B in cash. Beckman Coulter and Biosite said today they are in a definitive merger agreement to acquire all of Biosite's common stock for $85.00 per share. The deal is expected to close in Q2 of 2007.